Investview, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Investview, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $17.92M | Jun 29, 2018 |
| FY2018 | Mar 31, 2017 | $12.87M | Jun 29, 2018 |
| FY2017 | Mar 31, 2016 | $353.9K | Jul 13, 2017 |
| FY2016 | Mar 31, 2015 | $709.2K | Jul 14, 2016 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.26M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $52.38M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $67.92M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $61.85M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $72.23M | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | $38.27M | Jun 29, 2021 |
| FY2021 | Mar 31, 2020 | $24.18M | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | $29.66M | Jun 29, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($8.91M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.19M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $2.83M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($12.94M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($29.17M) | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | $565.8K | Jun 29, 2021 |
| FY2021 | Mar 31, 2020 | ($21.29M) | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | ($5.01M) | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | ($14.91M) | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | ($2.43M) | Jun 29, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($8.26M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.69M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $4.60M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($8.61M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($28.38M) | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | $774.4K | Jun 29, 2021 |
| FY2021 | Mar 31, 2020 | ($13.32M) | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | ($3.94M) | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | ($10.68M) | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | ($1.94M) | Jun 29, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $560.1K | Mar 29, 2024 |
| FY2023 | Dec 31, 2022 | $58.6K | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $76.7K | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | $891.2K | Jun 29, 2021 |
| FY2021 | Mar 31, 2020 | $1.70M | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | $878.9K | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | $454.2K | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | $1.20M | Jun 29, 2018 |
| FY2017 | Mar 31, 2016 | $1.98M | Jul 13, 2017 |
| FY2016 | Mar 31, 2015 | $5.54M | Jul 14, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.70M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $14.00M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $6.07M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $9.36M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $27.65M | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | $6.89M | Jun 29, 2021 |
| FY2021 | Mar 31, 2020 | $4.62M | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | ($2.98M) | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | ($1.05M) | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | ($1.64M) | Jun 29, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $544.6K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $461.9K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $2.56M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $15.27M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $2.02M | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | $2.93M | Jun 29, 2021 |
| FY2021 | Mar 31, 2020 | $5.25M | Jun 29, 2021 |
| FY2019 | Mar 31, 2018 | $11.3K | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | $0 | Jun 29, 2018 |
| FY2016 | Mar 31, 2015 | $64.8K | Jul 14, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.50M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $31.57M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $33.69M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $35.58M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $51.50M | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | $19.55M | Jun 29, 2021 |
| FY2021 | Mar 31, 2020 | $10.40M | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | $11.28M | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | $4.65M | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | $472.5K | Jun 29, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.57M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $14.37M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $14.90M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $18.20M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $22.56M | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | $23.25M | Jun 29, 2021 |
| FY2021 | Mar 31, 2020 | $24.66M | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | $9.92M | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | $6.41M | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | $4.70M | Jun 29, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.92M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $17.20M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $18.79M | Mar 28, 2025 |
| FY2024 | Dec 31, 2022 | $17.37M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $28.94M | Mar 29, 2024 |
| FY2022 | Mar 31, 2021 | ($3.70M) | Mar 31, 2023 |
| FY2021 | Mar 31, 2020 | ($14.26M) | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | $1.30M | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | ($1.78M) | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | ($4.23M) | Jun 29, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $873.7K | Mar 31, 2026 |
| FY2025 | Oct 11, 2024 | $873.7K | Mar 31, 2026 |
| FY2014 | Mar 31, 2013 | $123.6K | Jul 15, 2014 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($96.79M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($87.21M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($87.58M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($89.59M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($75.83M) | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | ($46.04M) | Jun 29, 2021 |
| FY2021 | Mar 31, 2020 | ($46.38M) | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | ($25.10M) | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | ($20.09M) | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | ($5.15M) | Jun 29, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.99M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $22.47M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $20.91M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $20.32M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $31.00M | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | $5.39M | Jun 29, 2021 |
| FY2021 | Mar 31, 2020 | $137.2K | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | $133.6K | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | $1.49M | Jun 28, 2019 |
| FY2019 | Mar 31, 2017 | $1.6K | Jun 28, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Mar 31, 2016 | $1.76M | Jul 13, 2017 |
| FY2016 | Mar 31, 2015 | $1.70M | Jul 14, 2016 |
| FY2015 | Mar 31, 2014 | $1.09M | Jul 14, 2015 |
| FY2014 | Mar 31, 2013 | $2.54M | Jul 15, 2014 |
| FY2012 | Mar 31, 2012 | $1.02M | Jul 1, 2013 |
| FY2011 | Mar 31, 2011 | $3.01M | Jun 29, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.85B | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 1.86B | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 2.33B | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 2.64B | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 2.90B | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | 2.98B | Jun 29, 2021 |
| FY2021 | Mar 31, 2020 | 3.21B | Jun 29, 2021 |
| FY2020 | Mar 31, 2019 | 2.64B | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | 2.17B | Jun 28, 2019 |
| FY2018 | Mar 31, 2017 | 125.89M | Jun 29, 2018 |